Jane Fonda's non-Hodgkin's lymphoma was in Stage II when diagnosed in 2022, but she announced in December 2022 that she was in remission and could stop chemotherapy, meaning the cancer was no longer actively progressing, though this doesn't necessarily mean a permanent cure. Lymphoma staging (like Stage II) indicates the cancer's extent at diagnosis, but remission signifies a successful response to treatment, making the current "stage" less relevant than the remission status.
For stage 4 non-Hodgkin lymphoma, the chance of surviving at least five years is about 64%. Survival rates vary depending on the type of non-Hodgkin lymphoma. Diffuse large B-cell lymphoma is the most common type of non-Hodgkin lymphoma. It is an aggressive type, so the survival rates are often lower.
10 Celebrities With Non-Hodgkin's Lymphoma
The stages of non-Hodgkin lymphoma
The staging system used for NHL is called the Lugano classification. It has four stages. It uses Roman numerals I (1), II (2), III (3), or IV (4). The higher the number, the more advanced the cancer is.
High-grade lymphomas need to be treated straight away, but tend to respond much better to treatment and can often be cured. The main treatments used for non-Hodgkin lymphoma are: chemotherapy. radiotherapy.
The most common cause of death was infection (33% of cases).
Most people with high-grade NHL have 6–8 cycles of chemotherapy or chemo-immunotherapy. You might then have radiotherapy if you had bulky disease before treatment, or if there is still active lymphoma.
A weakened immune system or an autoimmune condition.
Having a condition that affects the immune system can increase the risk of non-Hodgkin lymphoma. Conditions may include rheumatoid arthritis, psoriasis and Sjogren syndrome. The immune system also may be weakened after organ transplant.
According to the U.S. National Cancer Institute, 74% percent of people with non-Hodgkin lymphoma are alive five years after their diagnosis.
Non-Hodgkin lymphoma is caused by a change (mutation) in the DNA of a type of white blood cell called lymphocytes, although the exact reason why this happens isn't known. DNA gives cells a basic set of instructions, such as when to grow and reproduce.
In December 1993, Jackie was diagnosed with non-Hodgkin lymphoma. She announced her diagnosis in January 1994, stating that the initial prognosis was good. She began taking chemotherapy and continued to work at Doubleday, but by May, the cancer was pronounced terminal.
Survival data regarding Hodgkin vs. non-Hodgkin lymphoma depends on each patient's specific situation, but in general, the five-year relative survival rate for Hodgkin lymphoma is higher than that of non-Hodgkin lymphoma. One reason may be that non-Hodgkin lymphoma is often diagnosed when the cancer is more advanced.
Non-Hodgkin lymphoma is typically diagnosed in adults over age 60. Some viruses may make you more likely to get both Hodgkin and non-Hodgkin lymphoma. These include: Epstein-Barr virus, human immunodeficiency virus (HIV) and human T-cell lymphocytotropic virus.
NHL most often affects adults, but children can get it too. See Non-Hodgkin Lymphoma in Children. NHL usually starts in lymph nodes or other lymph tissue, but it can sometimes affect the skin.
Immunotherapy
The most common symptoms of CNS lymphoma include personality and behavioral changes, confusion, symptoms associated with increased pressure within the brain (e.g., headache, nausea, vomiting, drowsiness), weakness on one side of the body or the arms and legs, numbness, tingling, pain, and seizures.
Postmortem examination (70% of the entire sample) revealed evidence of lymphoma in 67 of 80 patients. The most frequent extranodal sites of involvement were the respiratory tract, bone marrow, liver, kidney, and gastrointestinal tract in that order. The most common cause of death was infection (33% of cases).
Survival for all non-Hodgkin lymphomas
around 80 out of every 100 people (around 80%) survive their cancer for 1 year or more after they are diagnosed. around 65 out of every 100 people (around 65%) survive their cancer for 5 years or more after diagnosis.
Overall, NHL is common in ages 65 to 74, with the median age being 67 years. Epstein-Barr virus-related (endemic) Burkitt lymphoma is more common in Africa.
Can stress cause non-Hodgkin's lymphoma? While stress can impact overall health, there is no direct evidence linking stress alone to the development of non-Hodgkin's lymphoma. The disease's causes are multifactorial, involving genetic, environmental, and immune system factors.
Having a family history of lymphoma does seem to increase your risk of lymphoma. Still, most people with lymphoma don't have a strong family history of it. Gene changes related to NHL are usually acquired (picked up) during life, rather than being inherited.
For some people, the lymphoma may never go away completely. These people may get regular treatments with chemo, radiation, or other therapies to help keep the lymphoma in check and to help relieve symptoms for as long as possible. Learning to live with lymphoma that doesn't go away can be difficult and very stressful.
Chemotherapy can have several side effects, the most significant of which is potential damage to your bone marrow. This can interfere with the production of healthy blood cells and cause the following problems: feeling very tired (fatigue) breathlessness.
The oncologist may plan to administer chemotherapy in cycles of 1–5 days each, with 2 days off, for a total of 7 days (7-day rule chemotherapy), or continuously for 1–5 days per session and rest for 3–4 weeks to allow the white blood cells and the body to recover and be ready for the next session.
This includes hair cells as well as lymphoma cells. For this reason, hair loss and other changes to your hair can be a side effect of lymphoma treatment. You might hear the word 'alopecia' used to refer to hair loss. You might experience this as a side effect of chemotherapy or radiotherapy.